middle.news
Rhythm Biosciences Cuts Losses 44% Amid New Subsidiary Launch
4:23am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
Rhythm Biosciences Cuts Losses 44% Amid New Subsidiary Launch
4:23am on Saturday 30th of August, 2025 AEST
Key Points
44% reduction in net loss to $3.83 million
Other income nearly doubles, up 91% to $3.33 million
Net tangible assets per share decline to negative 0.10 cents
Incorporation of new subsidiary RHY GeneType Pty Ltd in December 2024
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Rhythm Biosciences (ASX:RHY)
OPEN ARTICLE